FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964644808> ?p ?o ?g. }

• W1964644808 abstract "Hypermethylation of promoter CpG islands with associated loss of gene expression, and hypomethylation of CpG-rich repetitive elements that may destabilize the genome are common events in most, if not all, epithelial cancers. The methylation of 6,502 CpG-rich sequences spanning the genome was analyzed in 137 ovarian samples (ten normal, 23 low malignant potential, 18 stage I, 16 stage II, 54 stage III, and 16 stage IV) ranging from normal tissue through to stage IV cancer using a sequence-validated human CpG island microarray. The microarray contained 5' promoter-associated CpG islands as well as CpG-rich satellite and Alu repetitive elements. Results showed a progressive de-evolution of normal CpG methylation patterns with disease progression; 659 CpG islands showed significant loss or gain of methylation. Satellite and Alu sequences were primarily associated with loss of methylation, while promoter CpG islands composed the majority of sequences with gains in methylation. Since the majority of ovarian tumors are late stage when diagnosed, we tested whether DNA methylation profiles could differentiate between normal and low malignant potential (LMP) compared to stage III ovarian samples. We developed a class predictor consisting of three CpG-rich sequences that was 100% sensitive and 89% specific when used to predict an independent set of normal and LMP samples versus stage III samples. Bisulfite sequencing confirmed the NKX-2-3 promoter CpG island was hypermethylated with disease progression. In addition, 5-aza-2'-deoxycytidine treatment of the ES2 and OVCAR ovarian cancer cell lines re-expressed NKX-2-3. Finally, we merged our CpG methylation results with previously published ovarian expression microarray data and identified correlated expression changes. Our results show that changes in CpG methylation are cumulative with ovarian cancer progression in a sequence-type dependent manner, and that CpG island microarrays can rapidly discover novel genes affected by CpG methylation in clinical samples of ovarian cancer." @default.
• W1964644808 created "2016-06-24" @default.
• W1964644808 creator A5008367436 @default.
• W1964644808 creator A5027085526 @default.
• W1964644808 creator A5029797248 @default.
• W1964644808 creator A5054621218 @default.
• W1964644808 creator A5069934781 @default.
• W1964644808 creator A5070049424 @default.
• W1964644808 date "2008-09-30" @default.
• W1964644808 modified "2023-10-18" @default.
• W1964644808 title "DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage" @default.
• W1964644808 cites W1504303645 @default.
• W1964644808 cites W1571666545 @default.
• W1964644808 cites W1576432325 @default.
• W1964644808 cites W1903208568 @default.
• W1964644808 cites W1967064280 @default.
• W1964644808 cites W1968263601 @default.
• W1964644808 cites W1968513535 @default.
• W1964644808 cites W1981608682 @default.
• W1964644808 cites W1998541984 @default.
• W1964644808 cites W1999510229 @default.
• W1964644808 cites W2001258296 @default.
• W1964644808 cites W2015438948 @default.
• W1964644808 cites W2034967182 @default.
• W1964644808 cites W2043235003 @default.
• W1964644808 cites W2046509449 @default.
• W1964644808 cites W2059964041 @default.
• W1964644808 cites W2080308138 @default.
• W1964644808 cites W2087632344 @default.
• W1964644808 cites W2091778396 @default.
• W1964644808 cites W2096335059 @default.
• W1964644808 cites W2102179098 @default.
• W1964644808 cites W2104292638 @default.
• W1964644808 cites W2109223814 @default.
• W1964644808 cites W2121300496 @default.
• W1964644808 cites W2140219654 @default.
• W1964644808 cites W2144025143 @default.
• W1964644808 cites W2145909370 @default.
• W1964644808 cites W4211231408 @default.
• W1964644808 cites W4253059207 @default.
• W1964644808 doi "https://doi.org/10.1186/1755-8794-1-47" @default.
• W1964644808 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2566571" @default.
• W1964644808 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18826610" @default.
• W1964644808 hasPublicationYear "2008" @default.
• W1964644808 type Work @default.
• W1964644808 sameAs 1964644808 @default.
• W1964644808 citedByCount "69" @default.
• W1964644808 countsByYear W19646448082012 @default.
• W1964644808 countsByYear W19646448082013 @default.
• W1964644808 countsByYear W19646448082014 @default.
• W1964644808 countsByYear W19646448082015 @default.
• W1964644808 countsByYear W19646448082017 @default.
• W1964644808 countsByYear W19646448082018 @default.
• W1964644808 countsByYear W19646448082019 @default.
• W1964644808 countsByYear W19646448082020 @default.
• W1964644808 countsByYear W19646448082021 @default.
• W1964644808 countsByYear W19646448082022 @default.
• W1964644808 countsByYear W19646448082023 @default.
• W1964644808 crossrefType "journal-article" @default.
• W1964644808 hasAuthorship W1964644808A5008367436 @default.
• W1964644808 hasAuthorship W1964644808A5027085526 @default.
• W1964644808 hasAuthorship W1964644808A5029797248 @default.
• W1964644808 hasAuthorship W1964644808A5054621218 @default.
• W1964644808 hasAuthorship W1964644808A5069934781 @default.
• W1964644808 hasAuthorship W1964644808A5070049424 @default.
• W1964644808 hasBestOaLocation W19646448081 @default.
• W1964644808 hasConcept C104317684 @default.
• W1964644808 hasConcept C121608353 @default.
• W1964644808 hasConcept C140173407 @default.
• W1964644808 hasConcept C150194340 @default.
• W1964644808 hasConcept C153911025 @default.
• W1964644808 hasConcept C154253233 @default.
• W1964644808 hasConcept C189235521 @default.
• W1964644808 hasConcept C190727270 @default.
• W1964644808 hasConcept C2780427987 @default.
• W1964644808 hasConcept C33288867 @default.
• W1964644808 hasConcept C41091548 @default.
• W1964644808 hasConcept C502942594 @default.
• W1964644808 hasConcept C54355233 @default.
• W1964644808 hasConcept C86803240 @default.
• W1964644808 hasConceptScore W1964644808C104317684 @default.
• W1964644808 hasConceptScore W1964644808C121608353 @default.
• W1964644808 hasConceptScore W1964644808C140173407 @default.
• W1964644808 hasConceptScore W1964644808C150194340 @default.
• W1964644808 hasConceptScore W1964644808C153911025 @default.
• W1964644808 hasConceptScore W1964644808C154253233 @default.
• W1964644808 hasConceptScore W1964644808C189235521 @default.
• W1964644808 hasConceptScore W1964644808C190727270 @default.
• W1964644808 hasConceptScore W1964644808C2780427987 @default.
• W1964644808 hasConceptScore W1964644808C33288867 @default.
• W1964644808 hasConceptScore W1964644808C41091548 @default.
• W1964644808 hasConceptScore W1964644808C502942594 @default.
• W1964644808 hasConceptScore W1964644808C54355233 @default.
• W1964644808 hasConceptScore W1964644808C86803240 @default.
• W1964644808 hasIssue "1" @default.
• W1964644808 hasLocation W19646448081 @default.
• W1964644808 hasLocation W19646448082 @default.
• W1964644808 hasLocation W19646448083 @default.
• W1964644808 hasLocation W19646448084 @default.
• W1964644808 hasLocation W19646448085 @default.

• next